Claims for Patent: 4,833,130
✉ Email this page to a colleague
Summary for Patent: 4,833,130
| Title: | Treatment of human viral infections |
| Abstract: | Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of the 5'-mono, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose. |
| Inventor(s): | Rideout; Janet L. (Raleigh, NC), Barry; David W. (Chapel Hill, NC), Lehrman; Sandra N. (Durham, NC), St. Clair; Martha H. (Durham, NC), Furman; Phillip A. (Durham, NC) |
| Assignee: | Burroughs Wellcome Co. (Research Triangle Park, NC) |
| Application Number: | 07/110,946 |
| Patent Claims: |
1. A method of treating a human having an HTLV III virus infection comprising administering to said human an effective HTLV III virus treatment amount of 3'-azido-3'-deoxythymidine.
2. The method of claim 1 in which 3'-azido-3'-deoxythymidine is administered orally. 3. The method of claim 1 in which 3'-azido-3'-deoxythymidine is administered parenterally. 4. A method of treating a human having an HTLV III virus infection comprising administering to said human an effective HTLV III treatment amount of a pharmaceutically acceptable alkali metal, alkaline earth or ammonium salt of 3'-azido-3'-deoxythymidine. 5. The method of claim 4 in which the salt is administered orally. 6. The method of claim 4 in which the salt is administered parenterally. 7. A method of treating a human, having an HTLV III virus infection comprising orally or parenterally administering to a human an effective HTLV III virus treatment amount of a pharmaceutically acceptable salt of 3'-azido-3'-deoxythymidine. |
